SCHEDULE 13G: Atlantic Health Century International Group Discloses 5.62% Stake in Hong Kong Pharma Digital Technology Holdings Ltd
Beneficial Ownership Report
Atlantic Health Century International Group has reported a beneficial ownership of 5.62% in Hong Kong Pharma Digital Technology Holdings Ltd, holding 617,850 ordinary shares as of March 31, 2025.
Summary
- Atlantic Health Century International Group, a British Virgin Islands entity, has filed a Schedule 13G with the SEC.
- The filing indicates that Atlantic Health Century International Group beneficially owns 617,850 Ordinary Shares of Hong Kong Pharma Digital Technology Holdings Ltd.
- This ownership represents 5.62% of the Issuer's total outstanding Ordinary Shares.
- The percentage is calculated based on 11,000,000 Ordinary Shares of Hong Kong Pharma Digital Technology Holdings Ltd issued and outstanding as of March 31, 2025.
- Atlantic Health Century International Group holds sole voting power and sole dispositive power over all 617,850 shares.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing disclosing beneficial ownership, providing factual information without expressing positive or negative sentiment regarding the issuer's performance or outlook.
Positives
- A significant institutional investor, Atlantic Health Century International Group, has disclosed a 5.62% beneficial ownership stake in Hong Kong Pharma Digital Technology Holdings Ltd, potentially signaling confidence in the company.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant ownership stake by an institutional investor, which can influence market perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of the event which requires the filing of this statement (beneficial ownership calculation date) and the date as of which the 11,000,000 Ordinary Shares outstanding were calculated. |
| 06/05/2025 | Date the Schedule 13G statement was signed by Tianruyi Jin, Sole Director of Atlantic Health Century International Group. |
Keywords
Hong Kong Pharma Digital Technology Holdings Ltd, Atlantic Health Century International Group, Schedule 13G, beneficial ownership, ordinary shares, SEC filing, institutional investment, G6365B104
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.